Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12035-020-02022-0 http://scihub22266oqcxt.onion/10.1007/s12035-020-02022-0 32671688!7360695!32671688     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Neurobiol 2020 ; 57 (10): 4106-4116 Nephropedia Template TP {{tp|p=32671688|t=2020. Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics |pdf=|usr=}}{{32671688}} gab.com Text Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics JO: Mol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=32671688 #FOAvip The coronavirus disease of 2019 (COVID-19) is a pandemic disease that has taken the lives of many around the world. It is caused by severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2). To date, the USA, Italy, Spain, France, Russia, and the UK have been hit the hardest by the virus. However, death counts are still rising. Some nations have managed to "flatten" the death rate via protective measures such physical distancing, quarantine measures, and therapeutic management. The structure of the SARS-CoV-2 virus comprises of S proteins, M proteins, E proteins, hemagglutinin esterases, nucleocapsid proteins, and a 30-kb RNA genome. Viral proteases cleave these polyproteins and RNA-dependent polymerases replicate the genome. Currently, there are no effective therapies against this new disease. Numerous investigators are developing novel protease inhibitors, some of which have made it into clinical trials. Researchers are also attempting to develop a vaccine. In this review paper, we discuss the latest therapeutic developments against COVID-19. Graphical Abstract. Twit Text FOAVip Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics ????Mol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=32671688 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32671688 #FOAvip English Wikipedia <ref>{{Cite pmid|32671688}}</ref> Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics #MMPMID32671688 Kandimalla R; John A; Abburi C; Vallamkondu J; Reddy PH Mol Neurobiol 2020[Oct]; 57 (10): 4106-4116 PMID32671688show ga The coronavirus disease of 2019 (COVID-19) is a pandemic disease that has taken the lives of many around the world. It is caused by severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2). To date, the USA, Italy, Spain, France, Russia, and the UK have been hit the hardest by the virus. However, death counts are still rising. Some nations have managed to "flatten" the death rate via protective measures such physical distancing, quarantine measures, and therapeutic management. The structure of the SARS-CoV-2 virus comprises of S proteins, M proteins, E proteins, hemagglutinin esterases, nucleocapsid proteins, and a 30-kb RNA genome. Viral proteases cleave these polyproteins and RNA-dependent polymerases replicate the genome. Currently, there are no effective therapies against this new disease. Numerous investigators are developing novel protease inhibitors, some of which have made it into clinical trials. Researchers are also attempting to develop a vaccine. In this review paper, we discuss the latest therapeutic developments against COVID-19. Graphical Abstract. |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Coronavirus Infections/epidemiology/prevention & control/*therapy[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/epidemiology/*therapy[MESH] |Protease Inhibitors/*therapeutic use[MESH] |SARS-CoV-2[MESH]Current Status of Multiple Drug Molecules, and Vaccines: An Update in (epmc).pdf DeepDyve Pubget Overpricing